Pharma news
Americas
Fake pharmaceuticals not only harm innovators, they can have tragic consequences, and require a robust response from the authorities. LSIPR assesses how officials, particularly in South America, are responding to the threat. 1 November 2017
Americas
With the PTAB facing questions over its authority and even constitutionality, life sciences companies seem to be faring well, at least compared to other industries, as LSIPR finds out. 1 November 2017
Americas
Following the signing of a historic trade agreement with the EU, Canada now has a system of patent term extension. LSIPR considers the impact for pharmaceutical patentees. 1 November 2017
Pharma
Swiss pharmaceutical company Novartis has bolstered its oncology portfolio with the acquisition of Advanced Accelerator Applications. 1 November 2017
Americas
The Patent Trial and Appeal Board has agreed to rehear an inter partes review (IPR) filed by Hospira, a company now owned by Pfizer. 31 October 2017
Pharma
The English High Court has invalidated two patent claims protecting Copaxone (glatiramer acetate), a billion-dollar drug marketed by Teva. 27 October 2017
Americas
Merck Sharp & Dohme (MSD) has suffered a loss at the US Court of Appeals for the Federal Circuit, after the court affirmed an earlier finding of obviousness. 27 October 2017
Americas
Non-profit group the Initiative for Medicines, Access & Knowledge (I-MAK) has accused Gilead of obtaining “unmerited patents” for its hepatitis C medicine sofosbuvir. 26 October 2017
Pharma
Patent applicants have long wrestled with the question of how much experimental evidence to include in a new patent application. David Carling and Richard Wells of Potter Clarkson examine the issue in Europe. 26 October 2017
Americas
Sanofi has taken on Mylan in its latest lawsuit over Lantus (insulin glargine injection), which is used to help control the blood sugar level of those with diabetes. 25 October 2017